Q3 2021 Holdings
Filed 2021-11-15 | 75 holdings | $998.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $220.6M | 730,582 | 22.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $171.8M | 1,975,006 | 17.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $164.3M | 3,043,298 | 16.5% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $137.2M | 3,246,960 | 13.7% |
| Absci Corporation(ABSI) | COM | 00091E109 | $93.4M | 8,031,094 | 9.4% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $63.8M | 864,435 | 6.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $62.3M | 3,349,185 | 6.2% |
| Avita Medical Inc(RCEL) | COM | 05380C102 | $23.9M | 1,346,217 | 2.4% |
| Bioventus Inc(BVS) | COM CL A | 09075A108 | $21.1M | 1,489,856 | 2.1% |
| Alpha Teknova Inc(TKNO) | COM | 02080L102 | $18.0M | 725,000 | 1.8% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $8.5M | 1,044,434 | 0.8% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $8.5M | 696,377 | 0.8% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $768.0K | 12,957,222 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $225.7K | 2,131,796 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $225.3K | 3,425,455 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $204.5K | 7,529,329 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $198.6K | 20,799,303 | 0.0% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $194.4K | 7,483,706 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $173.5K | 2,191,019 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $164.1K | 2,793,708 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $151.2K | 5,317,477 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $137.0K | 4,031,521 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $120.9K | 4,078,112 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $115.7K | 6,466,277 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $114.5K | 5,619,914 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $112.2K | 861,401 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $103.5K | 1,982,432 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $99.7K | 587,374 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $92.7K | 3,093,077 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $87.8K | 1,869,030 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $84.2K | 2,550,205 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $84.2K | 2,008,001 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $79.9K | 1,878,520 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $67.4K | 2,567,696 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $64.2K | 901,491 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $63.2K | 542,932 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $60.6K | 2,381,958 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $60.1K | 2,687,444 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $52.7K | 2,505,118 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $52.0K | 3,083,501 | 0.0% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $51.9K | 222,526 | 0.0% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $49.2K | 3,972,270 | 0.0% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $49.0K | 1,120,388 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $47.5K | 127,502 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $47.2K | 120,710 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $46.8K | 8,258,345 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $45.1K | 4,541,009 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $38.2K | 7,458,660 | 0.0% |
| Medavail Holdings Inc | COM | 58406B103 | $34.2K | 11,724,726 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $32.5K | 3,816,709 | 0.0% |